Stability melphalan solutions during preparation and storageBOSANQUET, A. G.Journal of pharmaceutical sciences. 1985, Vol 74, Num 3, pp 348-351, issn 0022-3549Article

De nouveaux cytostatiques par voie oraleLONGUEVILLE, J.Louvain médical. 2005, Vol 124, Num 8, pp 345-347, issn 0024-6956, 3 p.Article

Cytolytic activities of benfluron metabolites and loss of transplantabilityMIKO, M; KREPELKA, J; MELKA, M et al.International journal of tissue reactions. 1989, Vol 11, Num 3, pp 143-151, issn 0250-0868, 9 p.Article

Biopharmazie der Urologika = Biopharmacie des médicaments pour un traitement en urologie = Biopharmacy of drugs for urological treatmentFICKWEILER, E.Pharmazie. 1988, Vol 43, Num 2, pp 148-150, issn 0031-7144Article

Antiémétiques au cours des traitements cytotoxiques = Antiemetic during cytolytic treatmentsPOUILLART, P.La Revue du praticien (Paris). 1993, Vol 43, Num 8, pp 1001-1006, issn 0035-2640Article

Chromosome abnormalities after cytostatic therapy, and distribution of fragile sites in peripheral blood lymphocytes of a breast cancer patientYAKOVLEVA, T. K; MONAKHOV, A. S; MOISEYENKO, V. M et al.Citologiâ. 1992, Vol 34, Num 2, pp 77-83, issn 0041-3771Article

Reciprocal biological activities of the cyclic tetrapeptides chlamydocin and HC-toxinWALTON, J. D; EARLE, E. D; STAHELIN, H et al.Experientia. 1985, Vol 41, Num 3, pp 348-350, issn 0014-4754Article

Activité cytostatique de Viscum cruciatum Sieber sur des cultures cellulaires. Toxicité aiguë = Cytostatic activity of Viscum cruciatum Sieber on cellular cultures. Acute toxicityAYUSO, M. J; DE MIGUEL, C; SAENZ, M. T et al.Annales pharmaceutiques françaises. 1985, Vol 43, Num 5, pp 459-461, issn 0003-4509Article

Cytotoxicity and immunostimulation : double attack on cancer cells with polymeric therapeuticsRIHOVA, Blanka; KOVAR, Lubomir; KOVAR, Marek et al.Trends in biotechnology (Regular ed.). 2009, Vol 27, Num 1, pp 11-17, issn 0167-7799, 7 p.Article

Direct intratumoral chemotherapyBRINCKER, H.Critical reviews in oncology/hematology. 1993, Vol 15, Num 2, pp 91-98, issn 1040-8428Article

La mise en place d'une unité centralisée de reconstitution des cytostatiques à l'hôpital Saint-JosephHUCHET, J; LE MANDAT, M; LARROUTUROU, P et al.Gestions hospitalières. 1990, Num 297, pp 482-487, issn 0016-9218Article

Biotinylierte Liganden in der Rezeptorlokalisation. Eine Alternative zur Immunohistochemie = Biotinylated ligands as markers for receptor-binding sites. An alternative for immunohistochemstryKAYSER, K; GABIUS, H.-J; GABIUS, S et al.Zentralblatt für Pathologie. 1991, Vol 137, Num 6, pp 473-478, issn 0863-4106Article

Proliferative Vitreoretinopathie = Vitréorétinopathie proliférative = Proliferative vitreoretinopathyWIEDEMANN, P; HEIMANN, K.Klinische Monatsblätter für Augenheilkunde. 1986, Vol 188, Num 6, pp 559-564, issn 0023-2165Article

Cellular pharmacokinetics of daunorubicin: uptake by leukaemic cells in vivo and fateTRILLET, V; LAKHAL, M; LANG, J et al.European journal of clinical pharmacology. 1985, Vol 29, Num 1, pp 127-129, issn 0031-6970Article

Effect of demecolane (Colcemid) on goldfish oocyte meiosis in vitroHABIBI, H. R; LESSMAN, C. A.Gamete research. 1986, Vol 13, Num 2, pp 103-114, issn 0148-7280Article

Leukotriene D₄ and indomethacin enhance additively the macrophage cytostatic activity in vitro towards MOPC-315 tumour cellsOPHIR, R; BEN-EFRAIM, S; BONTA, I. L et al.International journal of tissue reactions. 1987, Vol 9, Num 3, pp 189-194, issn 0250-0868Article

Evaluation of different cytotoxic and cytostatic measures for the in vitro micronucleus test (MNVit): Summary of results in the collaborative trialKIRKLAND, David.Mutation research. Genetic toxicology and environmental mutagenesis (Print). 2010, Vol 702, Num 2, pp 139-147, issn 1383-5718, 9 p.Article

Antioxidant, antimicrobial and cytotoxic activities of selected medicinal plants from YemenAL-FATIMI, Mohamed; WURSTER, Martina; SCHRÖDER, Gudrun et al.Journal of ethnopharmacology. 2007, Vol 111, Num 3, pp 657-666, issn 0378-8741, 10 p.Article

Synthesis and in vitro antiproliferative activity of new 1,3-(Oxytetraethylenoxy ) -cyclotriphosphazene derivativesSIWY, Mariola; SEK, Danuta; KACZMARCZYK, Bozena et al.Anticancer research. 2007, Vol 27, Num 3B, pp 1553-1558, issn 0250-7005, 6 p.Article

Extravasación de agentes citostáticos : Una complicación grave del tratamiento oncológico = Extravasation of cytostatic agents : A serious complication of oncological treatmentALFARO-RUBIO, Alberto; SANMARTIN, Onofre; REQUENA, Celia et al.Actas dermo-sifiliográficas (Ed. impresa). 2006, Vol 97, Num 3, pp 169-176, issn 0001-7310, 8 p.Article

The history of the oxazaphosphorine cytostaticsBROCK, N.Cancer. 1996, Vol 78, Num 3, pp 542-547, issn 0008-543XArticle

The genetic basic of resistance to cancer chemotherapyWOODHOUSE, J. R; FERRY, D. R.Annals of medicine (Helsinki). 1995, Vol 27, Num 2, pp 157-167, issn 0785-3890Article

Passage transplacentaire de l'épirubicine = Transplacental transfer of epirubicinGAILLARD, B; LENG, J.-J; GRELLET, J et al.Journal de gynécologie obstétrique et biologie de la reproduction. 1995, Vol 24, Num 1, pp 63-68, issn 0368-2315Article

Inhibition of Meth-A tumor cell proliferation in combined use of disulfiram with catalaseMASHIBA, H; MATSUNAGA, K.Toxicology letters. 1992, Vol 61, Num 1, pp 75-80, issn 0378-4274Article

Clinical, genetic and regulatory consequences of exposure to mutagensRÜDIGER, H. W.Annales de génétique (Paris). 1991, Vol 34, Num 3-4, pp 173-178, issn 0003-3995Article